Post by Novartis

Name: Decades of leadership in chronic myeloid leukemia (CML) continue to shape what comes next, with new
Uploaded: 2026-06-03T13:00:01.343Z
Channel: Novartis
Description: Decades of leadership in chronic myeloid leukemia (CML) continue to shape what comes next, with new long term CML data from Novartis presented at the 2026 ASCO® Annual Meeting. We are partnering with

4,679,135 followers

Decades of leadership in chronic myeloid leukemia (CML) continue to shape what comes next, with new long term CML data from Novartis presented at the 2026 ASCO® Annual Meeting. We are partnering with patient organizations like CML Advocates Network, with the commitment to deliver lasting impact for people living with CML. #ReimaginingOncology #ASCO26 #WeGoFurther #NovartisOncology

Video Content